2-(3,4-Dimethyl-phenyl)-4-methyl-[1,2,4]oxadiazolidine-3,5-dione | 21818-83-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3,4-Dimethyl-phenyl)-4-methyl-[1,2,4]oxadiazolidine-3,5-dione
• 英文别名: 2-(3,4-Dimethylphenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione
• CAS: 21818-83-7
• 化学式: C₁₁H₁₂N₂O₃
• 分子量: 220.228
• InChiKey: RYZIPKSGTQYWEY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  49.8
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Small Molecule Modulators of pRb Inactivation
  申请人：The Wistar Institute of Anatomy and Biology

  公开号：US20140323442A1

  公开（公告）日：2014-10-30

  The present invention provides a small molecule treatment of diseases/conditions caused by a virus carrying a viral oncoprotein. In one embodiment, the virus which carries the viral oncoprotein is HPV. The small molecule useful herein includes thiadiazolin-3,5-dione compounds having an optionally substituted aryl group bound to one nitrogen atom of said thiadiazolin-3,5-dione compound. The small molecules may also be administered with a compound which inhibits binding of HPV E6 to p53. In one embodiment, the thiadiazolin-3,5-dione compound has formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein R 1 and R 2 are defined herein.
• SMALL MOLECULE MODULATORS OF PRB INACTIVATION
  申请人：The Wistar Institute of Anatomy and Biology

  公开号：US20170000772A1

  公开（公告）日：2017-01-05

  The present invention provides a small molecule treatment of diseases/conditions caused by a virus carrying a viral oncoprotein. In one embodiment, the virus which carries the viral oncoprotein is HPV. The small molecule useful herein includes thiadiazolin-3,5-dione compounds having an optionally substituted aryl group bound to one nitrogen atom of said thiadiazolin-3,5-dione compound. The small molecules may also be administered with a compound which inhibits binding of HPV E6 to p53. In one embodiment, the thiadiazolin-3,5-dione compound has formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein R 1 and R 2 are defined herein.
• US9447060B2
  申请人：——

  公开号：US9447060B2

  公开（公告）日：2016-09-20
• [EN] SMALL MOLECULE MODULATORS OF PRB INACTIVATION<br/>[FR] MODULATEURS À PETITE MOLÉCULE D'INACTIVATION DE PRB
  申请人：WISTAR INST

  公开号：WO2013070586A1

  公开（公告）日：2013-05-16

  The present invention provides a small molecule treatment of diseases/conditions caused by a virus carrying a viral oncoprotein. In one embodiment, the virus which carries the viral oncoprotein is HPV. The small molecule useful herein includes thiadiazolin-3,5-dione compounds having an optionally substituted aryl group bound to one nitrogen atom of said thiadiazolin-3,5- dione compound. The small molecules may also be administered with a compound which inhibits binding of HPV E6 to p53. In one embodiment, the thiadiazolin-3,5- dione compound has formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein R 1 and R 2 are defined herein.